Premier Heart’s Multifunction Cardiogram (MCG) Technology Description and Historical Efforts on Phase III/IV Validation Trials over the years.

Solving the most challenging problems in accurate and early diagnosis of heart (and brain) diseases, Joseph T. Shen, a self-taught BioCybernetics Systems Engineer an emancipated physician

Most intellectually honest allopathic cardiologists treating patients with heart failure would acknowledge this reality: more than half of heart failure patients test “normal” on all the costly, potentially deadly, harmful, time-consuming, outdated, and unscalable analog conventional allopathic cardiology tests.

Furthermore, the “diagnosis” of heart failure is often too little and too late. No wonder more people die from heart failure, including younger populations, due to the lack of a proper, accurate, early detection diagnostic tool. There is a desperate need for a transformative solution.

Bougie academic and pharmaceutical Molochianism permeates institutions and industry, where they ignore critical issues like knowledge and solutions for some of the most challenging, patient-centric, life-saving, and cost-effective innovative problems. Stagnation, blatant corruption, diabolical late-stage sickness-seeking profiteering, and total loss of trust in allopathic medical institutions plague the masses. To seek the ultimate truth and fundamentally change the directions, I have dedicated half my life to developing Premier Heart’s MCG (Multifunction Cardiogram) Technology Platform—a fully patient-centered, humanistic, evidence- and data-driven, life-saving solution—after a long, perilous, and challenging journey. The good news is that we have successfully brought Premier Heart’s Multifunction Cardiogram Technology to life, and we are moving away from the nightmarish artificial reality imposed by the corrupt allopathic monopolistic medical-industrial complex.

Premier Heart’s Multifunction Cardiogram Technology demonstrates its value by enabling quick, accurate, and potentially life-saving diagnoses at the bedside in under 10 minutes—something traditional cardiology tools cannot achieve! We boldly entered the “Super Domain Intelligence Deep Human and Machine Learning AI” realm when the world sidelined AI during the two periods of “AI winter.” Not surprisingly, industry “experts” consider what MCG offers as IMPOSSIBLE and INCONCEIVABLE, including the “EXPERTS” IN THE LEGACY CARDIOLOGY. They insist that technology like ours will not be possible until at least 2050! But we have proven them wrong. I believe Premier Heart’s MCG technological innovation exemplifies authentic leadership in driving the much-needed transformation, and what we have developed is just the beginning of the 21st-century digital industrial revolution in healthcare.

We are working to systematically understand the internal Universe of biological beings from a physiological perspective. Our foundational work has successfully developed the first rule-based, thoroughly vetted, strategically selected, responsible, accountable, moral, and ethical empirical evidence-driven AI digital platform. This platform is safe and effective for practical bedside clinical use, accessible anywhere with broadband internet, to aid diagnosis and further exploration. Unlike generative AI models like ChatGPT or Google’s Gemini, which can sometimes deceive, gaslight, propagandize, confabulate, and hallucinate, our Rule-&-Reality-Based AI differs entirely from conventional models. Like Elon Musk, who aims to understand the Universe around us, he has started building his model. We have successfully created the first biological and physiological beings exploration model to investigate our internal Universe and to distinguish our efforts from those of Elon’s team. 

This technology description tells about our work.

Ischemic heart disease, including Coronary artery disease (CAD), is the leading single cause of death in the developed world. Between 15% and 20% of all hospitalizations are the direct result of ischemia from multiple causes and lead to an estimated 23 million people dying annually. The record denotes that the industry captured arrogant, pompous, monopolistic, irresponsible, unaccountable, profit-driven, pseudoscientific, dishonest, baseless, fraudulent, and unsalable analog 19th-century allopathic Cardiology has a failed legacy.

Electrocardiography (EKG)-based methods, now 130 years old and rigid, are still routinely used as the initial screening and diagnosis tools. However, our database accumulated over the decades has shown that their accuracy rates are around 13-15% in detecting obstructive coronary artery disease (CAD), not to mention misdiagnosing other critical conditions, including, but not limited to, metabolic heart dysfunctions, cardiomyopathy, myocardial inflammation/myocarditis, and often misdiagnosed causes of heart failure. We have learned these facts through years of studies based on Premier Heart’s extensive real-world datasets, which we have accumulated over the decades. This discovery revealed two startling facts:

1. No one, especially across the legacy generations of academic echo chambers, had questioned or investigated whether ECG truly worked as intended in its 125-year history until we began thoroughly examining real-world data to justify the need for a better and more valuable new system.

2. The EKG industry, supported by academics (or the so-called thought leaders) in corrupt pay-to-play academic echo chambers, is an institutionally normalized scam, a disgusting “Kabuki Dance Theater” of captured and paid soulless academic mouthpieces.

We have also thoroughly examined the sensitivity and specificity of stress test methods, such as stress echo, nuclear imaging, and pharmacological tests. Collectively, these methods show an accuracy of less than 50%! They are minimally effective and raise safety concerns, especially in single-vessel CAD cases. They account for two-thirds of the false positive results, leading to unnecessary coronary angiograms and interventions.

Coronary angiography and CTA remain the gold standards for diagnosing "Obstructive Coronary Artery Disease" and assessing the need for profitable coronary interventions during the same procedure, despite questionable patient benefits. Evidence shows that the entire interventional cardiology field is resource-intensive, time-consuming, unscalable, expensive, invasive, and associated with a relevant procedure-related complication rate (< 2%), morbidity (0.03-0.25%), and mortality (0.01-0.05%). Additionally, interventions like PTCA/Stenting or coronary bypass surgeries have repeatedly been shown to be ineffective and offer little or no benefit for patients with chronic CAD compared to conservative medical management. Furthermore, traditional medical and interventional paradigms of American Allopathic Cardiology lead to unacceptably high rates of Major Adverse Cardiac Events (MACE), resulting in premature deaths and injuries due to a fundamental lack of understanding of the physiological reasons behind these pathologies.

The hallmark of the failed legacy of allopathic cardiology is a fundamental lack of innovation in a much-needed safe, effective, accurate, and scalable non-invasive “do-no-harm” bedside tool to DETECT signs of physiological dysfunction in their EARLY stages, enabling effective disease reversal and timely prevention. All conventional diagnostic tools detect late-stage diseases, with many treatments often being too little and too late. These legacy phenomena exemplify decades-long systematic technological stagnation in a corrupt, ossified, and obsolete system that Peter Thiel has criticized and lamented for years. We have witnessed and investigated these phenomena firsthand! Unfortunately, Peter has been correct all along.

Premier Heart’s Multifunction Cardiogram (MCG) fundamentally addresses this issue and advances medicine into the 21st century! The future of healthcare lies in early detection and monitoring of signs of physiological dysfunctions from the earliest to the latest stages, aiming to identify root causes to prevent and reverse the progression of disease, primarily by adopting an optimal, healthier lifestyle, living in a cleaner environment, and eating wholesome, nutritious foods free from ultra-processed foods and toxic chemicals. This approach helps extend a healthier lifespan and ultimately saves lives.

Premier Heart’s Multifunction Cardiogram (MCG) offers a new method for diagnosing metabolic heart diseases, including myocardial ischemia caused by various root issues related to supply-and-demand imbalances, such as coronary heart disease. After decades of research and development by two generations of dedicated scientists, clinicians, and engineers, MCG technology has proven its ability to detect myocardial ischemia caused by obstructive coronary disease (CAD) through multiple independent clinical validation trials, achieving high sensitivity (89-100%), specificity (83-94%), and accuracy (90-100%). We are now building a large, decentralized data registry with millions of participants worldwide to explore the root causes of heart and brain pathologies in detail. This ongoing effort aims to enhance the algorithm’s complexity, enable new modeling approaches, ensure trustworthy and reproducible verification, and support future validation into the 22nd Century and beyond.

Premier Heart’s MCG model provides characterization directly in plain language for at least 26 pathological and physiopathological conditions, helping to address the lack of accurate detection of myocardial ischemia caused by coronary artery disease and other non-ischemic pathologies, as well as difficult-to-diagnose conditions such as cardiomyopathy and myocarditis.

Theoretical Foundation:

Einthoven historically presumed the myocardium to be a single-point electrical generator, emitting three-dimensional vectors into infinity. Unfortunately, after 125 years, our in-depth studies have concluded that the Einthoven hypothesis has NEVER worked to deliver the intended effectiveness in detecting and quantifying heart disease. All the technologies built based on Einthoven's ossified theory have never delivered the clinical usefulness clinicians need to be effective diagnosticians. This rationale gives us the basis for researching and developing Premier Heart's MCG technology.

To transform the industry, our research that led to the development of Premier Heart's MCG began by describing two core physiological properties of the heart mathematically: first, the myocardium is a viscoelastic solid using the Lagrange coordinate; second, blood is a non-Newtonian fluid at low and intermediate shearing states via the Euler coordinate. We adopted the “Laplace transform” to combine these two coordinates into a single complex mathematical equation, the “Lagrange-Euler” Equation, which has guided our system’s technological development.

We also adopted MIT/Harvard Professor Nobert Weiner’s “Control Theory” or his Cybernetic Systems Mathematical Principals, combined with the “LaGrange-Eüler Equation,” as our systems technology design guiding compass pointing to the system’s physiolgical north, which states that one can extract the unprecedented and vast amount of system internal functional information physiologically from the communications between an input (Lead V5) and an output (Lead II) or vice versa, to understand how the targeted system functions fully. Our work has proven that Professor Weiner's ground-breaking theory works as envisioned. We are honored to be the first to deliver the definitive proof.

The Data collection and reporting process:

Quinquinquagintillion is the sum of Google (1x10 to the 100th power) and the number of visible atoms in the entire Universe (1x10 to the 68th power). It also roughly equals at least 10 times the total number of mitochondria in the human body, which ranges from 70K to 100K trillion, acting as its biological energy grid! Imagine how extraordinary this discovery truly is!!! The mitochondrial network supplies all cellular energy needs and directly and critically influences cell survival. Therefore, the precise energy demands of the AMPK master switch depend on the mitochondrial balance in each cell. Additionally, scientists have shown that a mitochondrial AMPK pool exists across various tissues and includes isoforms conserved between mice and humans. The direct, localized physical connection between mitochondria and AMPK underscores the vital role of the mitochondrial network in maintaining cellular energy for survival. 

The AMPK Switch Pathway is distinct. It remains a key metabolic and genetic survival switch throughout our lives. Diet, exercise, intermittent fasting, caloric restriction, and any medication that reduces cardiovascular events more than it lowers the targeted risk factor activate AMPK. Fatty liver, excessive visceral fat, and uncontrolled hyperinsulinemia (which causes the mTOR pathway to be turned on and AMPK to be turned off) due to frequent eating, obesity, alcoholism, tobacco smoking, and other factors lead to chronic disease and early death. We constantly evaluate the balance between the mTOR and AMPK pathways in near real-time throughout life, as they control cellular aging, death, rejuvenation, and survival processes. The patient's portable device automatically records 4 to 5 cycles of 82 seconds each of complete resting ECG analog signals from leads II and V5. These signals are then digitized, encrypted, and securely transmitted, along with the patient’s demographic information, to a central data center for analysis. An animal model in mice demonstrated that Cisd2 is vital for maintaining normal cardiac functions.

1. Cisd2 is crucial for maintaining normal heart function and the structural integrity of the myocardium. A lack of Cisd2 in knockout mice impairs electromechanical performance and leads to myocardial degeneration in young mice. The levels of Cisd2 protein in cardiomyocytes are vital for maintaining intercalated disc integrity, which allows individual cardiomyocytes to function together as a synchronized organ (as MCG measures local and global asynchrony). Cisd2 deficiencies result in intercalated disc defects, including lateralization of the gap junctions, uneven distribution of desmosomes, and breakdown of the fascia adherence. “Persistently high Cisd2 protein levels appear to preserve intercalated discs. Age-related deterioration affects intercalated disc integrity in aged wild-type mice."

2. In our research using real-life datasets, we have found that diffuse early myocarditis can worsen over time and develop into more severe forms of chronic or acute Rheumatic Heart Structural Anomalies. The reason for this progression—from diffuse functional myocarditis to more localized structural Rheumatic Heart Disease—has now become clearer. Cisd2 deficiency causes mitochondrial Ca++ overload and impairs mitochondrial functions. Cisd2 is essential for preserving normal respiration (oxidative phosphorylation), membrane potentials, and minimizing ROS production. The amount of Cisd2 decreases by 50% in aged mice compared to young mice.

We have created the first deep learning platform based on human physiology knowledge to provide a RULE-BASED, clean, and vetted empirical data. It emphasizes responsible, honest internal and external verification, validation, replication, and reproducing results to ensure 100% fidelity and achieve the highest accuracy. The goal is to detect physiological dysfunctions early for prevention and disease reversal, assisting clinicians in delivering the best outcomes at the lowest costs so people can live healthier, longer lives.

1. We perform Discrete Fourier Transformations (DFT) on the acquired analog ECG data, converting the signals into digital format. Then, we apply signal averaging to produce high- quality 82- second digitized signal segments for further analysis.

2. In the next step, we use system theory mathematical models based on Lagrange- Euler theory. We combine the results of six mathematical transformations- coherence, phase angle shift, impulse response, cross- correlation, transfer function, and amplitude histogram- derived from the auto- power spectra of the recorded ECG leads.

3. These six transformations (12 phases) reveal unprecedented insights into the electrophysiological and mathematical properties of the heart muscles, relating to blood flow, physiological functions, and myocardial performance. The MCG technology offers groundbreaking information akin to what the James Webb Space Telescope has uncovered in the universe. The insights we provide about the heart and brain are invisible or nonexistent in conventional medicine.

4. Ironically, industry experts with limited understanding of our technology believe what we have developed is impossible. They insist that such technology won' t be feasible until 2050 or later. They ignore our existence and have even tried to censor and erase us- imagine that!

5. These functions generate the post- DSP 168 empirically derived mathematical elements, enabling the discovery of vast parameters- up to 10 to the 168 th power- over the decades. The parameter patterns from a single patient match those obtained from over 250, 250,000 individuals (50% men and 50% women), of whom 60% had various degrees of CAD, confirmed by coronary angiography, including FFR, classical, and functional syntax scores- the gold standards of interventional cardiology. Developing, cleaning, vetting, training, verifying, and validating our neural network diagnostic algorithms has taken decades, addressing the limitations of fragmented, surface- focused diagnoses such as “obstructive coronary artery disease " or” atrial fibrillation,” without exploring root causes or systemic issues common in traditional medicine.

6. Each MCG test pattern has been validated and correlated with the presence, absence, and severity of CAD, from as little as 30% single- vessel disease to complete occlusion of coronary arteries, with or without collateral circulation- self- healing mechanisms of the heart- and other invisible conditions related to supply and demand imbalances, which are impossible to detect with conventional analog methods.

7. The database also contains results of the patients having:

   1. Clinically Normal people ages 14 to 100

   2. 50/50 male/female ratio

   3. No evidence of visible CAD

   4. cardiac ischemia disease

   5. one or more non-ischemic cardiac diseases

   6. both cardiac ischemia and non-ischemic cardiac disease(s)

   7. many forms of heart diseases (e.g., arrhythmias, hypertrophy, cardiomyopathy) with or without CAD

Clinical studies have shown that MCG™ is sensitive to 90-100%, with 0-7% false-negative results, and specific to 85-99%, with 1-15% false-positive results, in detecting ischemia due to coronary artery disease (CAD). However, patients with adequate collateral circulation may test low or normal on MCG. Cardiologists may label these patients as false negative cases. On the other hand, patients who have NO Visible CAD can have very high ischemia and other abnormal expressions on MCG due to many root causes (see below). Cardiologists may falsely label these cases as false positives.

In addition, due to our deep understanding of creating AI applications and the potential pitfalls. Another important aspect of our work is that we separate the Production environment and the Development environment to ensure safety and effectiveness without endangering our customers and those they serve:

The Development Environment:

Our development environment is an open-source deep learning framework for neural networks. We allow developers to reach far and wide to ensure that the learning is complete without hindrance. We are adding additional learning layers and wide-ranging data input to optimize learning. This environment allows maximum creativity to flourish. Once we are satisfied with an application and have responsibly implemented a “locked down” version, we will move it to production to ensure the operationalized platform performs, by measuring the system’s physiology and reporting relevant information to support diagnostic decision-making.

The production environment:

The production platform is a rule-and-reality-based, empirical-data-driven, locked-down system. We repeatedly optimize, automate, verify, and validate the customer-facing version of our analysis engine both internally and externally until we are sure it operates as intended without deception, propaganda, hallucinations, or falsified reporting. Once confirmed, we lock it down and launch it for commercial use. Each update undergoes the same rigorous process.

ISCHEMIA RESULTS and the MCG SEVERITY SCORES:

Note: when encountering alternating global/local/borderline/no ischemia patterns, one must consider the possibilities of functional ischemia. Shockingly, in reality, the ALMIGHTY “obstructive coronary ischemia” does NOT rank first on the differential diagnosis list, certainly not the NUMBER ONE differential diagnosis at all. We now know that coronary interventions, such as PTCA, Stenting, and the Coronary Bypass Artery Grafting (CABG) procedure, produce zero clinical benefits to patients diagnosed with chronic coronary artery disease. One must consider the rationale for referring a patient for such procedures.

Word of Caution: Thanks to our decades of dedicated, shoestring budgets but determined, meticulous empirical data mining to train your neuro-network, we have discovered and defined the digital parameters of 1x10 to 168th power, or “Quinquinquagintillion” to digitally mirror the biological mitochondrial network system (containing greter than 10 x of ~ 70K to ~100k trillion mitochondria) of the human or animal heart and brain. MCG detects, quantifies, and monitors myocardial ischemia or cellular quiescence as a result of ANY cause that leads to supply and demand imbalances physiologically, including but not limited to mitochondrial dysfunctions due to the following partial list of differentials:

1. Anemia (Invisible)

2. Hypoxia (Invisible)

3. Hypoxemia (Invisible)

4. Hyperinsulinemia, central obesity (particularly too much belly or visceral fat, fatty liver), and overweight due to overeating/snacking (Invisible, blindsided)

5. Insulin resistance (Invisible), early-stage Diabetes, metabolic dysfunction

6. Diabetes (Invisible)

7. Overweight and Obesity (Invisible)

8. Nutrient Deficiencies (Invisible)

9. Poor sedentary lifestyles (Invisible)

10. Women's Heart Dysfunctions due to pre-eclampsia, eclampsia, polycystic ovarian disease, Broken Heart Syndrome, Insulin Resistance, Obesity, etc. (Invisible)

11. Maternal-fetal, Pediatrics, and Adolescent Preventive lifestyle medicine applications (current aims of development)

12. Environmental toxins such as heavy metals, insecticides, pesticides, and herbicides (Invisible)

13. Eating ultra-processed foods such as seed oils, sugar, flours, alcohol, etc., (Invisible)

14. Fatty liver disease (Alcohol or non-alcoholic) and excessive belly fat

15. Tobacco smoking (Invisible)

16. Air pollution (Invisible)

17. Narcotics, such as Fentanyl, Cocaine (Invisible)

18. The Effects of Cyanide (Invisible)

19. Any root cause leading to all stages of heart failure (Invisible)

20. Coronary artery disease, early stages, non-obstructive types (hardly visible)

21. Endothelial dysfunction (Invisible)

22. Microvascular disease (Invisible)

23. Neuroendocrine disorders (Invisible)

24. Acute or chronic exposure to stress (Invisible)

25. Thyroid dysfunction (Invisible)

26. Autoimmune disorders (Invisible)

27. Prescription medications, fitness programs, and supplements (Invisible)

28. Impact of, or lack thereof, implantable medical devices (Invisible)

29. Impact of cancer and treatment options, such as chemotherapy, radiation, immunological bone marrow transplants, etc. (Invisible)

30. Religious rituals or lifestyle choices such as fasting and intermittent fasting (Invisible)

31. Impact of treatment guidelines from alphabet medical institutions, or lack thereof (Invisible)

32. Medical Society AMA CPT Code recommendations, Insurance companies’ coverage policies (Invisible)

33. Impact of socioeconomic status (Invisible)

34. Effects of poorly administered general anesthesia (Invisible)

35. High-altitude sickness (Invisible)

36. Deep-sea-diving accidents (the Bends) (Invisible)

37. Space travelers’ physiological effects on humans and animals (Invisible but very useful)

38. The physiological impact of Space travel (Invisible)

39. coronary angiogram, visible obstructive coronary artery disease of varying degrees (less than 15% in our database).

40. Any root causes disrupting normal mTOR, AMPK, and cellular autophagy functions (Invisible)

41. Type I, II, III, IV, and V Diabetes.

Therefore, do not consider invisible conditions visible only to specialized equipment (such as any vessel less than 7mm on an angiogram) as false positives that could lead to misdiagnosis. Clinicians, thoroughly explore the patient's journey and identify the root cause to truly help your patients! Do not irresponsibly categorize your patients under a "Syndrome-X” label and leave them behind. You are their last hope for survival, doctors! Instead of unwittingly or intentionally becoming salespeople for drugs, devices, and procedures, leverage real-world evidence and physiology knowledge to make decisions that serve your patients' best interests and become the genuine healers you set out to be!

I have decided to post the article link below describing how people can use it as a basis to interpret their own MCG reports:

Global ischemia refers to ischemia of the entire heart, whereas local ischemia refers to partial heart involvement, nothing more or less.

As you can see, legacy allopathic cardiologists are flying blindfolded without knowing their most effective diagnostic tools for identifying only small, disconnected parts of the broader physiological dysfunctions of the cardiometabolic system and its environment. They overlook the majority of root causes such as metabolic, immunological, environmental, pharmacological, dietary, and sedentary lifestyle factors that contribute to heart attacks and heart failure. Please share this blog post with everyone, especially your cardiologist if you know one.

The following tables illustrate the shortcomings and the urgent need for the fundamental transformation we bring to the table:

Here are some examples of how we help people with metabolic dysfunctions impacting their hearts:

And our journey to validate our claims in real-world clinical settings through blinded independent cream-of-the-crop ethical volunteering investigators without any industry standard pay-to-play or corrupt quid pro quo:

Please see my response to a senior medical director at a major insurance company about how I believe there is a right and best way to evaluate a diagnostic test or a drug.

“Hello, Dr. Xxxx; we all know that nearly 90% of the published data by the academic literature and guidelines made through medical societies, CMS, ICER, and other well-established organizations are flawed and based on pseudoscientific key opinion leaders” pinions rather than ethically and morally collected transparently 💯 % objective empirical data without the corrupt “cherry-picked data sets” to fit the preordained narratives and deliver predetermined outcomes. I believe that this colossal systemic corruption is the root cause of the out-of-control chronic diseases in America.

Thus, I recommend that your group look beyond the conventional legacy and use real-world empirical evidence and the scientific method to evaluate the work we have consistently done to build our technology platform. Thank you!

His reaction has been positive thus far. We shall see if they will ultimately surrender to make the right decision!

Finally, it is heartwarming to witness the cultural shift toward what we have been working on: rethinking and redesigning the legacy of the American Medical system's corrupt, ossified dumpster fire since the 1990s to build a new system everyone deserves.

Our future is bright: We are building a people-centered world of computational electrophysiology that features an individually owned, vetted, and monetized decentralized data network managed through a blockchain ledger. This setup ensures integrity, honesty, and ethical standards in how our health data is used for advanced machine learning. The goal is to improve healthcare to provide the best outcomes at the lowest cost for everyone. There will be no middlemen in this system. Our users will verify and validate diagnostic criteria, drugs, supplements, devices, procedures, insurance policies, clinical guidelines, peer-reviewed studies, and legislation, allowing them to independently assess their core values without being influenced by corrupt pay-to-play schemes, cherry-picked data supporting preselected narratives, or predetermined results. The system will evaluate anyone who contributes to and analyzes data within this new “keeping-everyone-honest” data network, and they will be judged and fully compensated based on the value of their contribution, merit, and capability.

Our B2C direct personal monitoring devices will lead the way in establishing this robust data network for 21st-century healthcare delivery.

We must no longer allow corrupt operators to access people’s data to gaslight and manipulate them diabolically, ultimately plundering them. There is no need to lie for profit; people will earn a decent living by telling the truth and delivering their best work.

Enough! Time to move on and move forward with us!

Joseph T. Shen, the first BioCybernetics Systems Engineer

As Sir. Arthur C. Clarke once said, "The only way to truly understand the limits of the possible is to push past them and explore the impossible.”

This philosophy guides our work at MCG, where we constantly push the boundaries of what is achievable in bioengineering and technology.

I am an independent, emancipated, fully recovered, rebellious physician who stands for personal freedom and sovereignty. In 1998, I became a self-taught pioneer in bio-cybernetic systems and information technology engineering. With my deep knowledge of how the legacy of allopathic medicine was a dumpster fire of “artificial reality” that gaslit, scammed, and plundered the unsuspecting masses. From thereon, I have focused on developing computational bio-cybernetics, Lagrangian mechanics systems, and deep machine learning of heart-and-brain-saving super-intelligent detection and diagnostic decision-making technologies for the new Century. I have never looked back!

Researcher and Technology Developer

Managing Member

Premier Heart, LLC

Premier Heart International, LLC

Premier Heart Japan, Inc.

Emergency MCG USA, Inc.

110 Main Street, Suite 201-88

Port Washington, NY 11050

Tel: 516-883-3383 ex 8102

Fax: 516-883-5812

Mobile: 516-603-6368 (Please alert me who you are with a text message first; please do not respond to unknown numbers. I WILL respond as soon as possible.)

Email: jtshenmd@premierheart.com (mailto:jtshenmd@premierheart.com)